Just like all other lawsuits, a Roundup lawsuit is also complex, and a person cannot understand all its aspects on their own. You need to consult a lawyer if you think Roundup has caused you cancer after being exposed for a certain period of time.
Roundup is a very famous herbicide that is commonly used all across the USA in houses, farms, nurseries, etc., to control pests. Now you must be thinking: how can it cause cancer? Well, there is an active ingredient in it called glyphosate. This is linked to cancer and is widely supported by research and evidence. Roundup has been declared a “probable human carcinogen” by the World Health Organization’s International Agency for Research on Cancer (IARC). Right after that, thousands of claims were filed against Roundup that its long-term usage has caused non-Hodgkin lymphoma and other types of cancers.
Monsanto, a well-known company renowned for making chemicals, was originally behind Roundup. It was acquired by Bayer in 2018. And since then, it has been facing legal issues. You cannot get an accurate estimation or an exact figure for a settlement amount. This is because it depends on several factors. The payouts vary according to the type of cancer, severity of disease, availability of evidence, and how strongly your case was presented in court.
Please be advised that the information shared on this page or the settlement amounts mentioned are general estimations or have been taken from information available online based on previous cases. This does not guarantee future settlement payouts. These figures are based on similar previous litigations and estimated costs. These figures are meant to provide you with a general idea and should not be taken as definitive for your own case.
Want to get an accurate estimation of your case value? Contact a qualified attorney to get personalized assistance. If you or a loved one used Roundup and developed Non-Hodgkin’s Lymphoma, you may be eligible for a lawsuit. Contact Joya Injury Law for a free consultation.
Brief Background
When the IARC declared glyphosate as a cancer-causing agent in 2015, people started filing cases against Monsanto. They said the company was well aware of the risk of cancer involved in using glyphosate, but they did not inform their customers. The company did nothing to warn the users, and as a result, hundreds and thousands of people were put at risk of developing cancer.
All the claims made by the victims were compiled into a federal multidistrict litigation called MDL 2741 in the Northern District of California. Meanwhile, thousands of other related cases were processed in state courts.
Bayer announced a global settlement budget of $10-$11 billion in June 2020 to resolve roughly 100k existing cancer claims. Despite this, settlement talks and court cases are still underway. Almost 4,400 cases are still unresolved in federal court, and many more in state courts as of November 2025.
Large Jury Verdicts
Most cases are settled privately, but in a few trials, juries have rendered major verdicts. Examples include:
- Dewayne Johnson (California, 2018): The first Roundup trial ended with a $289 million verdict (later reduced to $21.5 million) after a jury found that exposure to Roundup contributed to the plaintiff’s non-Hodgkin lymphoma.
- Pilliod v. Monsanto (California, 2019): A jury awarded a married couple $2.055 billion, later reduced to $87 million on appeal.
- Ernest Caranci (Pennsylvania, 2024): A jury awarded $177 million to a former groundskeeper who developed cancer allegedly caused by Roundup exposure.
- Pennsylvania Verdict (June 2024): Another jury initially granted $2.25 billion, which a judge later reduced to $400 million.
- Barnes v. Bayer (Georgia, March 2025): A Georgia jury awarded $2.1 billion (about $65 million compensatory and $2 billion punitive) to a plaintiff who developed non-Hodgkin lymphoma.
- Missouri Supreme Court Ruling (October 2025): The court allowed a $611 million award to stand for three plaintiffs who claimed Roundup caused their cancer.
What can be inferred from these large payouts? This shows that if cases are high-profile, juries are willing to impose heavy amounts on Bayer. But do keep in mind that this does not show the range of a typical individual case settlement. It usually ranges between $5K and $250K, all depending upon the severity of the disease and how strongly the case was presented.
Roundup Settlement Update 2025
Bayer has been facing legal lawsuits since 2015. The company has paid more than 11 billion dollars in settlements and jury awards. Here are the key updates regarding Roundup settlement cases:
November 2025
Roundup victims are insisting that the MDL judges transfer their cases to the district court so that trials can get started. Many cases have completed their discovery phase, where evidence and information are shared. Now, the plaintiffs want the trial to start so they can get their fair share of compensation. Currently, many more people are filing claims against Roundup as they expect to get settlement amounts in return.
October 2025
More than 4,400 Roundup cases are still pending, and Bayer’s shareholders are asking for a $38 million settlement. They claim that Bayer misled them and did not warn them about the legal lawsuits the company might face.
The Missouri court also rejected Bayer’s latest appeal. 4 plaintiffs got a verdict of $611 million, and Bayer appealed against the verdict. The court rejected the appeal and validated the plaintiff’s verdict.
As Roundup victims are receiving settlements, Bayer is trying to escape liability. To put pressure on Congress, Bayer has made separate groups. It is done to pass laws that save the pesticide companies from lawsuits, and it is called preemption.
September 2025
On September 20, 2025, the Illinois Appellate Court upheld Monsanto’s September 2023 defense verdict in a Cook County Roundup case. Plaintiffs raised concerns about juror bias and inaccurate guidance on causation. The court said the juror was frustrated with the lawyers but was still fair. The brief instructions on the cause were fine since there was only one defendant. The court also said no new trial was needed, even though the lawyers were sick, because the trial was almost finished and delaying it would have been too much for the jurors.
On September 17, 2025, the Ninth Circuit just heard arguments in a Roundup case. The main question was whether the trial court made a mistake by rejecting a general-causation expert and dismissing the injury suit. The case comes from the Northern District of California’s Roundup MDL. There, the court had excluded a peer-reviewed methodology and ruled in favor of Monsanto. During the hearing, the judges pushed both sides on how courts should handle expert evidence and bad science, while also noting the MDL’s long history and big record. The decision hasn’t come out yet. For now, the Roundup MDL isn’t getting a lot of attention.
On September 4, 2025, a California MDL judge gave plaintiffs access to Bayer’s 2018 Monsanto acquisition diligence documents. Through these documents, plaintiffs can get the idea of how much Bayer and Monsanto knew about the possible danger associated with the use of Roundup. According to Bayer, these new documents cannot potentially make a change.
On September 2, 2025, Bayer filed for approval of a new herbicide named “CropKey” in the EU, the US, Brazil, and Canada. This herbicide is based on icafolin-methyl instead of glyphosate, and Bayer is promoting it as a safer next-gen product. The company is still facing thousands of Roundup cases, juries are giving major verdicts, and the link between glyphosate and cancer is getting stronger.
August 2025
Some people are now filing the same case in different courts. They expect a faster result in this way. But this causes problems because courts have to decide which case to prioritize.
On August 7, 2025, in one case, Mangoba v. Monsanto, a court in Hawaii paused the case because the same person had already filed a similar lawsuit in Missouri two years earlier. Both lawsuits said Mangoba got non-Hodgkin lymphoma after using Monsanto products like Roundup and PCBs. Mangoba said he only wanted the Hawaii case to continue. However, he never officially dropped the Missouri case. The court said both cases had the same people, facts, and issues, and Missouri was the place he first chose. The court then used the Colorado River Doctrine, which lets federal courts wait when there is a similar case in a state court.
On August 4, 2025, a case in the Superior Court of Delaware was filed by 92 plaintiffs across the United States. They claimed that they got non-Hodgkin lymphoma after using Roundup.
On August 1, 2025, Bayer added $1.37 billion to the money it has set aside for lawsuits. Now, Bayer has a total of $7.4 billion reserved. However, they have paid around $10 billion to settle older cases.
July, 2025
Bayer offered a settlement to Albert “Ab” Grantges from Texas. He claimed that Roundup caused him non-Hodgkin lymphoma. The lawsuit was in Missouri, and the exact payout is not known.
On July 21, 2025, Senator Cory Booker introduced the Pesticide Injury Accountability Act to give people a federal right to sue. This is because states like Iowa and Idaho had laws that protect pesticide companies from lawsuits if the EPA approved their products. These laws stopped people who got sick from Roundup, including non-Hodgkin lymphoma, from going to state courts.
On July 22, 2025, the Roundup case criteria expanded.
Previously, only people with strict, long-term Roundup exposure could file claims. Now, the rules are looser, and anyone exposed to Roundup who later developed non-Hodgkin’s lymphoma may be able to file a case.
On July 28, 2025, Bayer’s board extended CEO Bill Anderson’s contract by three years. He stated that the company may try to settle the cases within 12–18 months or even stop making Roundup. The court asked the Justice Department for its opinion on whether to hear Bayer’s appeal about Roundup. Anderson called the Supreme Court’s move “encouraging.” However, investors were concerned, and Bayer’s shares dropped by 4.2%.
June 2025
Bayer must pay $700 million to three people who got non-Hodgkin’s lymphoma from Roundup. A Missouri jury awarded damages ranging from $5.6 million to $38 million each, along with a share of $500 million in punitive damages.
On June 17, 2025, a new study from the Ramazzini Institute found that rats exposed to glyphosate, even at “safe” levels, developed rarer tumors like leukemia. Over 1,000 rats were studied for two years, and all exposed groups had more tumors than rats not given glyphosate.
On June 16, 2025, just before a verdict in St. Louis County, Monsanto settled a Roundup lawsuit. The plaintiff was a man from Texas. He had non-Hodgkin lymphoma from using Roundup.
On June 6, 2025, in a Missouri trial, emails showed that Dr. Thomas Sorahan, paid by Monsanto, may have influenced the International Agency for Research on Cancer (IARC) review. Donna Farmer of Monsanto admitted she often edited scientific papers without being listed as an author. Plaintiffs say this shows Monsanto shaped science to protect glyphosate.
On June 2, 2025, Bayer quietly restarted settlement talks in high-exposure Roundup cases, even while publicly claiming to “fight until the science wins.”
May 2025
On May 27, 2025, a Missouri court confirmed a $611 million verdict against Monsanto. Plaintiffs with non-Hodgkin’s lymphoma claimed Monsanto knew glyphosate in Roundup caused cancer but didn’t warn users.
On May 19, 2025, Bayer was reportedly thinking about a Chapter 11 bankruptcy for Monsanto. This could push all current and future Roundup lawsuits into the bankruptcy system. Bayer has already paid over $10 billion in settlements. The company’s 2025 market cap is $25.65 billion, making full payouts difficult.
On May 2, 2025, Federal Roundup cases in the MDL rose from 4,415 to 4,432.
April 2025
Bayer continued to appeal a 2023 court decision where John L. Durnell was awarded $1.25 billion. Durnell claimed that the use of Roundup caused him cancer.
March 2025
A claimant in Georgia was awarded $2 billion by a jury. He claimed that frequent use of Roundup caused a decline in his health. However, Bayer planned to appeal the verdict. As of March 2025, there are 4,414 active lawsuits against Bayer.
February 2025
No new cases were added to the federal Roundup MDL. Around this time, Bayer was also working on legal strategies to protect itself from more lawsuits.
What Average Payout Can I Expect?
Because most settlements are confidential, there is no official “average” payout. Nevertheless, multiple legal publications have reported ranges based on public information. Their estimates cluster around $150,000–$160,000 per claimant, with settlement ranges extending from a few thousand dollars to a few hundred thousand dollars.
The average settlement amount for those diagnosed with non-Hodgkin’s lymphoma linked to Roundup exposure typically ranges from $150,000 to $160,000. Earlier global settlement frameworks—such as the one announced in 2020 for approximately $10 billion—produced average individual payouts of around $105,000 after applying points-based scoring systems.
Recent updates from 2024–2025 suggest that newer claimants may receive slightly higher compensation, depending on factors like case strength, severity of illness, duration of Roundup exposure, and claimant age.
Overall, these figures represent approximate averages derived from aggregated settlement data and publicly reported case outcomes across the United States.
Why the Averages Vary
Several factors explain why the “average” settlement figure differs between sources:
- Confidentiality and variability: Many settlements include confidentiality clauses; exact numbers are rarely disclosed. Reported averages are based on a combination of leaked data, lawyer statements, and estimations from large settlement funds.
- Timing of settlements: Early settlements in 2020–2021 covered many cases and made the average payout look lower. Later settlements from 2023–2025 involve more serious injuries and larger payouts, which are raising the average.
- Case differences: Each plaintiff’s exposure level, cancer severity, and financial losses differ widely. Averages, therefore, mask the distribution, where some plaintiffs receive only a few thousand dollars while others receive multi‑million‑dollar verdicts.
- Gross vs. net amounts: Reported averages typically reflect gross settlement values. Plaintiffs’ actual recovery is lower after attorney fees, court costs, and reimbursement of medical liens. For example, settlement communications reviewed by reporters indicated an average gross payout of roughly $160,000, but this would be reduced by contingency fees (often 30–40 %) and lien repayments.
Settlement Ranges and Tiers
As per the majority of sources, normally, the amounts of Roundup settlement fall within a range of $5,000 to $250,000. However, in some cases, this amount may be increased, depending upon the severity of the case. This settlement system is done through a “points system,” which was used in the 2020 global settlement. According to this system, each case is given points on the basis of:
- Cancer type and severity: People with severe or advanced non‑Hodgkin lymphoma get more points.
- Duration and intensity of exposure: People who use Roundup on a daily basis, like farmers and landscapers, receive higher points. Whereas, people who use Roundup occasionally get lower points.
- Age and health at diagnosis: People who were young and healthy and diagnosed with cancer get more points because it affects their lives more.
- Treatment requirements and prognosis: Those who go through chemotherapy, radiation, or stem cell transplant receive way more points than others.
- Other losses: Income loss, pain and suffering, and other economic or emotional damages contribute to the final settlement.
After the points are added up, the claimants are placed into different settlement levels or “tiers.” People in the higher tiers get larger payments, while those in the lower tiers receive smaller ones. If someone disagrees with their score, they can ask for a review, but only once.
Common Damages that Impact the Average Payout
Severity of Illness
The most important factor is the severity and type of cancer. People with life-threatening types of non-Hodgkin lymphoma, or those who have died, receive the largest amount of settlement. If cancer is mild or under control, the settlement amounts get slightly lower. Similarly, if someone faces multiple myeloma or leukemia because of glyphosate, their case is also considered strong.
Causation and Exposure
To receive a settlement, it is mandatory to prove that Roundup is the cause of cancer. Evidence includes:
- Purchase receipts
- Employment records
- Proof of usage patterns through a witness
- Medical documentation
Stronger evidence increases the chances of a higher settlement.
Medical Costs and Economic Damages
Claimants who undergo costly treatments like chemotherapy or radiation receive higher settlements. If a user has lost his job and is now unable to earn, his lost wages are also included. On the other hand, if an individual is still able to work and earn, and treatment was not very costly, he will get a relatively lesser amount of settlement.
Non‑Economic Damages
These are the factors that are not measured in terms of money, such as emotional suffering. If a claimant has faced distress, they will get a larger settlement.
Age
Younger claimants usually receive higher payouts because cancer affects their life expectancy and future earnings more.
Evidence and Legal Representation
Plaintiffs with proper documentation and records receive higher settlement amounts. If they have an experienced lawyer who is an expert in negotiations and evidence presentation, the settlement can increase further.
Location and Trends
The amount of settlement varies from state to state. For example, in Missouri and Pennsylvania, juries have awarded more compensation than in other states. However, in some states, the jury is not very sympathetic, which results in a lesser settlement. Differences in laws and evidence standards also play a major role.
Influence of the Points System and Global Settlements
Bayer decided to settle the cases by arranging a fund of about $10.9 billion in June 2020 to cover roughly 95,000 claims. The company also reserved an extra $1.25 billion for later cases. After that, Bayer added $1.37 billion more to the reserves, which shows that the company might have to pay additional settlements. For these global settlements to run smoothly, the main procedure used is the “points system”. Candidates who agree to the settlement get their money faster but cannot go to court. However, claimants who think that their case is strong prefer to go to court rather than agree to the settlement so that they get more money from the jury.
Examples Illustrating the Range of Awards
While most plaintiffs receive settlements within the typical range, some cases demonstrate the extremes:
- Lower‑end payouts: In the global settlement, a significant number of claimants reportedly received $5,000–$20,000. These awards went to plaintiffs with less evidence of exposure or milder illnesses.
- Average payouts: Many plaintiffs received awards in the $100,000–$160,000 range based on factors such as moderate exposure and medically documented non‑Hodgkin lymphoma. One set of settlement communications leaked in 2020 indicated an average gross value of $160,000 per plaintiff.
- Higher‑end settlements: Some plaintiffs, especially those with strong evidence of daily exposure and severe, terminal cancer, received $200,000–$250,000 or more. However, these amounts are still modest compared to jury verdicts.
- Multi‑million‑dollar verdicts: A small number of cases that went to trial resulted in verdicts of millions or billions of dollars (e.g., $2.1 billion in March 2025). Such verdicts are often reduced on appeal but remain far above typical settlement values.
Settlements vs. Trials
Even though victims can get large payouts through trials, most people prefer not to choose this route. The reason is that once a case goes to trial, it takes too much time, and there is a chance of losing or getting a reduced payment amount if the defendant appeals. Trials sometimes take years to resolve, while settlement amounts are guaranteed and can be quicker. So it depends on the person which route they want to choose.
Ongoing Lawsuits
If we talk about the ongoing cases, there are still more than 40,000 cases in both federal and state courts. More and more people are filing cases against Bayer when they are diagnosed with cancer. Bayer has set aside an amount of $1.37 billion for future settlements. Many legal experts believe that there can be more rounds of settlements. So more people want the federal courts to send their cases back to local courts. The reason is that they want to handle their cases individually rather than waiting for group settlements.
Legal Updates
The interesting thing to mention here is that Bayer is trying its best to avoid future lawsuits against it, so it can avoid heavy payments in the form of settlement amounts. In fact, it is seeking preemption, which means to override state law so that people cannot sue it. It is asking for a law that would stop cases against it. The court so far has rejected this and said no to Bayer, and trials are still going on. One important thing to mention here is that in Missouri and Pennsylvania, the courts have upheld large verdicts against Bayer. If at any stage the Supreme Court decides to look at Bayer’s case, it may affect all ongoing lawsuits. But as of November 2025, the U.S. Supreme Court hasn’t made any decision yet.
Possible Bankruptcy
Some law experts are speculating that Bayer may declare bankruptcy for their Monsanto division because the lawsuits are too costly. What does that mean for the plaintiffs? Well, this situation can be alarming for them. The reason is that for people whose cases are still pending, it may delay the payment or reduce its amount. The good part is that Bayer has not declared its bankruptcy yet, is paying for verdict amounts, and has also set aside money for future claims.
The Bottom Line
You cannot exactly know the average Roundup cancer settlement amount. The reason is clear: it depends on multiple factors. Additionally, these settlements are usually made privately, so the only way to know about them is through online platforms or directly from lawyers’ websites. It may vary from a few thousand dollars to billions of dollars. However, as the above-mentioned cases have shown, these heavy payments can be reduced on appeal.
Just take this guide as a reference. And above all, keep in mind that with strong evidence and the right legal representation, you can recover the maximum compensation you deserve.